Vault-13

Altium Capital Management LLC

NEW YORK, NY · CIK 1746382 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$236.5m reported value -17.6% vs Q1 2022
120positions
29.0%in top 10
26 new 16 added 13 reduced 23 sold out vs Q1 2022

Options: 4 call positions ($7.7m notional), 2 put positions ($5.8m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CHINOOK THERAPEUTICS INC COM ADRO ADRO 615,000 $10.8m4.55% 4.55% AddedShares held: Q3 2021 465.0k, Q4 2021 545.0k, Q1 2022 545.0k, Q2 2022 615.0k +70.0k +70,000 12.8%
2 BELLUS HEALTH INC NEW COM NEW BLU BLU 912,000 $8.4m3.56% 3.56% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 912.0k -538.0k -538,006 -37.1%
3 ADMA BIOLOGICS INC COM ADMA ADMA 4,000,000 $7.9m3.35% 3.35% AddedShares held: Q3 2021 0, Q4 2021 3.3m, Q1 2022 3.3m, Q2 2022 4.0m +700.0k +700,000 21.2%
4 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 1,162,869 $7.4m3.13% 3.13% ReducedShares held: Q3 2021 0, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 1.2m -1.3m -1,333,655 -53.4%
5 PEPPERLIME HEALTH ACQUSTN CO CLASS A ORD SHS CLASS A ORD SHS 735,000 $7.3m3.07% 3.07% NewShares held: Q3 2021 0, Q4 2021 735.0k, Q1 2022 0, Q2 2022 735.0k
6 LANTHEUS HLDGS INC COM LNTH LNTH 88,000 $5.8m2.46% 2.46% AddedShares held: Q3 2021 290.0k, Q4 2021 272.0k, Q1 2022 40.0k, Q2 2022 88.0k +48.0k +48,000 120.0%
7 STAAR SURGICAL CO COM PAR $0.01 STAA STAA 75,000 $5.3m2.25% 2.25% NewShares held: Q3 2021 0, Q4 2021 26.0k, Q1 2022 0, Q2 2022 75.0k
8 INSMED INC COM PAR $.01 INSM INSM 268,000 $5.3m2.24% 2.24% UnchangedShares held: Q3 2021 203.4k, Q4 2021 203.4k, Q1 2022 268.0k, Q2 2022 268.0k
9 GLAUKOS CORP COM GKOS GKOS 114,000 $5.2m2.19% 2.19% AddedShares held: Q3 2021 0, Q4 2021 81.0k, Q1 2022 94.0k, Q2 2022 114.0k +20.0k +20,000 21.3%
10 CYMABAY THERAPEUTICS INC COM CBAY CBAY 1,750,000 $5.2m2.18% 2.18% UnchangedShares held: Q3 2021 0, Q4 2021 1.8m, Q1 2022 1.8m, Q2 2022 1.8m
11 NOCTURNE ACQUISITION CORP ORDINARY SHARES ORDINARY SHARES 500,000 $5.1m2.15% 2.15% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
12 QUIDELORTHO CORP COM QDEL QDEL 50,000 $4.9m2.05% 2.05% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
13 INSPIRE MED SYS INC COM INSP INSP 24,000 $4.4m1.85% 1.85% AddedShares held: Q3 2021 26.0k, Q4 2021 23.0k, Q1 2022 16.0k, Q2 2022 24.0k +8.0k +8,000 50.0%
14 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 75,000 $4.3m1.81% 1.81% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 22.5k, Q2 2022 75.0k +52.5k +52,500 233.3%
15 GUARDANT HEALTH INC COM GH GH 105,000 $4.2m1.79% 1.79% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 105.0k
16 MYRIAD GENETICS INC COM MYGN MYGN 221,000 $4.0m1.70% 1.70% AddedShares held: Q3 2021 158.0k, Q4 2021 190.0k, Q1 2022 114.7k, Q2 2022 221.0k +106.3k +106,290 92.7%
17 CHEMOCENTRYX INC COM CCXI CCXI 160,000 $4.0m1.68% 1.68% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 160.0k
18 EUCRATES BIOMEDICAL ACQU COR SHS SHS 400,000 $4.0m1.67% 1.67% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
19 NEVRO CORP COM NVRO NVRO 89,000 $3.9m1.65% 1.65% AddedShares held: Q3 2021 51.0k, Q4 2021 42.0k, Q1 2022 77.0k, Q2 2022 89.0k +12.0k +12,000 15.6%
20 AKOYA BIOSCIENCES INC COM AKYA AKYA 296,000 $3.8m1.61% 1.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 296.0k
21 INOGEN INC COM INGN INGN 156,000 $3.8m1.60% 1.60% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 156.0k
22 TREVI THERAPEUTICS INC COM TRVI TRVI 1,284,000 $3.6m1.53% 1.53% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.3m
23 VERASTEM INC COM COM 3,000,000 $3.5m1.47% 1.47% AddedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 3.0m, Q2 2022 3.0m +49.0k +49,000 1.7%
24 DEXCOM INC COM DXCM DXCM 44,000 $3.3m1.39% 1.39% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 44.0k -6.0k -6,000 -12.0%
25 XTANT MED HLDGS INC COM NEW XTNT XTNT 6,246,291 $3.2m1.37% 1.37% UnchangedShares held: Q3 2021 6.3m, Q4 2021 6.2m, Q1 2022 6.2m, Q2 2022 6.2m
26 CARA THERAPEUTICS INC COM COM 353,200 $3.2m1.36% 1.36% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 165.0k, Q2 2022 353.2k +188.2k +188,200 114.1%
27 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 98,000 $3.2m1.36% 1.36% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 47.1k, Q2 2022 98.0k +50.9k +50,923 108.2%
28 KARYOPHARM THERAPEUTICS INC COM COM 700,000 $3.2m1.34% 1.34% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 645.0k, Q2 2022 700.0k +55.0k +55,000 8.5%
29 LIVANOVA PLC SHS LIVN LIVN 50,000 $3.1m1.32% 1.32% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 50.0k
30 OCULAR THERAPEUTIX INC COM OCUL OCUL 695,000 $2.8m1.18% 1.18% UnchangedShares held: Q3 2021 556.0k, Q4 2021 695.0k, Q1 2022 695.0k, Q2 2022 695.0k
31 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 440,000 $2.8m1.17% 1.17% UnchangedShares held: Q3 2021 197.5k, Q4 2021 261.0k, Q1 2022 440.0k, Q2 2022 440.0k
32 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 85,000 $2.7m1.15% 1.15% AddedShares held: Q3 2021 0, Q4 2021 54.0k, Q1 2022 54.0k, Q2 2022 85.0k +31.0k +31,000 57.4%
33 KURA ONCOLOGY INC COM KURA KURA 147,000 $2.7m1.14% 1.14% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 147.0k
34 908 DEVICES INC COM MASS MASS 125,000 $2.6m1.09% 1.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 125.0k
35 KORU MEDICAL SYSTEMS INC COM KRMD KRMD 995,500 $2.5m1.07% 1.07% UnchangedShares held: Q3 2021 954.1k, Q4 2021 995.5k, Q1 2022 995.5k, Q2 2022 995.5k
36 TURMERIC ACQUISITION CORP CL A CL A 254,000 $2.5m1.06% 1.06% UnchangedShares held: Q3 2021 254.0k, Q4 2021 254.0k, Q1 2022 254.0k, Q2 2022 254.0k
37 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 50,000 $2.4m1.03% 1.03% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 50.0k
38 KEROS THERAPEUTICS INC COM KROS KROS 88,000 $2.4m1.03% 1.03% ReducedShares held: Q3 2021 126.0k, Q4 2021 116.0k, Q1 2022 126.0k, Q2 2022 88.0k -38.0k -38,000 -30.2%
39 SHOCKWAVE MED INC COM SWAV SWAV 12,000 $2.3m0.97% 0.97% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 23.0k, Q2 2022 12.0k -11.0k -11,000 -47.8%
40 IVERIC BIO INC COM OPHT OPHT 236,000 $2.3m0.96% 0.96% UnchangedShares held: Q3 2021 328.1k, Q4 2021 329.1k, Q1 2022 236.0k, Q2 2022 236.0k
41 SARISSA CAPITAL ACQUISITN CO CL A CL A 225,000 $2.2m0.94% 0.94% UnchangedShares held: Q3 2021 225.0k, Q4 2021 225.0k, Q1 2022 225.0k, Q2 2022 225.0k
42 ADICET BIO INC COM COM 150,000 $2.2m0.93% 0.93% ReducedShares held: Q3 2021 142.3k, Q4 2021 263.0k, Q1 2022 155.0k, Q2 2022 150.0k -5.0k -5,000 -3.2%
43 AVIDITY BIOSCIENCES INC COM RNA RNA 150,000 $2.2m0.92% 0.92% ReducedShares held: Q3 2021 225.0k, Q4 2021 225.0k, Q1 2022 243.0k, Q2 2022 150.0k -93.0k -93,000 -38.3%
44 GOSSAMER BIO INC COM GOSS GOSS 260,000 $2.2m0.92% 0.92% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 260.0k
45 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 22,000 $2.1m0.91% 0.91% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 22.0k
46 COLLEGIUM PHARMACEUTICAL INC COM COLL COLL 116,000 $2.1m0.87% 0.87% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 116.0k
47 GIGINTERNATIONAL1 INC COM COM 200,000 $2.0m0.85% 0.85% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
48 TG VENTURE ACQUISITION CORP UNIT 08/15/2028 UNIT 08/15/2028 200,000 $2.0m0.85% 0.85% UnchangedShares held: Q3 2021 0, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
49 LAKESHORE ACQUISITION I CORP ORDINARY SHARES ORDINARY SHARES 200,000 $2.0m0.84% 0.84% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
50 CHAVANT CAPITAL ACQUISITN CO ORDINARY SHARES ORDINARY SHARES 200,000 $2.0m0.84% 0.84% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
51 JIYA ACQUISITION CORP COM CL A COM CL A 200,000 $2.0m0.84% 0.84% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
52 HILLMAN SOLUTIONS CORP COM HLMN HLMN 221,000 $1.9m0.81% 0.81% AddedShares held: Q3 2021 142.0k, Q4 2021 142.0k, Q1 2022 196.0k, Q2 2022 221.0k +25.0k +25,000 12.8%
53 ILLUMINA INC COM ILMN ILMN 10,000 $1.8m0.78% 0.78% ReducedShares held: Q3 2021 10.0k, Q4 2021 17.5k, Q1 2022 11.0k, Q2 2022 10.0k -1.0k -1,000 -9.1%
54 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 224,541 $1.8m0.75% 0.75% UnchangedShares held: Q3 2021 370.6k, Q4 2021 225.0k, Q1 2022 224.5k, Q2 2022 224.5k
55 KARUNA THERAPEUTICS INC COM COM 13,000 $1.6m0.70% 0.70% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 21.0k, Q2 2022 13.0k -8.0k -8,000 -38.1%
56 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 73,000 $1.6m0.68% 0.68% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 66.2k, Q2 2022 73.0k +6.8k +6,804 10.3%
57 1847 GOEDEKER INC *W EXP 06/02/202 *W EXP 06/02/202 6,103,824 $1.6m0.67% 0.67% UnchangedShares held: Q3 2021 6.9m, Q4 2021 6.1m, Q1 2022 6.1m, Q2 2022 6.1m
58 OUTSET MED INC COM OM OM 103,880 $1.5m0.65% 0.65% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 52.0k, Q2 2022 103.9k +51.9k +51,873 99.7%
59 DIGITAL HEALTH ACQUISITION C UNIT 11/02/2026 UNIT 11/02/2026 150,000 $1.5m0.64% 0.64% UnchangedShares held: Q3 2021 0, Q4 2021 150.0k, Q1 2022 150.0k, Q2 2022 150.0k
60 AULT DISRUPTIVE TECHS CORP COM COM 150,000 $1.5m0.64% 0.64% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 150.0k, Q2 2022 150.0k
61 REZOLUTE INC COM NEW RZLT RZLT 411,000 $1.3m0.56% 0.56% NewShares held: Q3 2021 0, Q4 2021 230.0k, Q1 2022 0, Q2 2022 411.0k
62 MORPHIC HLDG INC COM MORF MORF 60,000 $1.3m0.55% 0.55% UnchangedShares held: Q3 2021 60.0k, Q4 2021 60.0k, Q1 2022 60.0k, Q2 2022 60.0k
63 TAILWIND ACQUISITION CORP COM CL A COM CL A 128,414 $1.3m0.54% 0.54% UnchangedShares held: Q3 2021 128.4k, Q4 2021 128.4k, Q1 2022 128.4k, Q2 2022 128.4k
64 IMMUNOGEN INC COM IMGN IMGN 280,000 $1.3m0.53% 0.53% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 920.0k, Q2 2022 280.0k -640.0k -640,000 -69.6%
65 ALTIMMUNE INC COM NEW ALT ALT 98,659 $1.2m0.49% 0.49% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 322.0k, Q2 2022 98.7k -223.3k -223,341 -69.4%
66 PROMETHEUS BIOSCIENCES INC COM COM 39,000 $1.1m0.47% 0.47% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 39.0k
67 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 83,000 $1.1m0.46% 0.46% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 115.0k, Q2 2022 83.0k -32.0k -32,000 -27.8%
68 RELATIVITY ACQUISITION CORP UNIT 02/10/2027 UNIT 02/10/2027 100,000 $1.0m0.43% 0.43% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 100.0k
69 MURPHY CANYON ACQUISITION CO UNIT 01/25/2027 UNIT 01/25/2027 100,000 $1.0m0.43% 0.43% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 100.0k
70 INDUSTRIAL HUMAN CAPITAL INC COM COM 100,000 $1.0m0.42% 0.42% UnchangedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
71 WESTERN ACQSTN VENTURES CORP UNIT 09/01/2026 UNIT 09/01/2026 100,000 $1.0m0.42% 0.42% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 100.0k
72 BCLS ACQUISITION CORP COM CL A COM CL A 100,000 $990.0k0.42% 0.42% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
73 OMEGA ALPHA SPAC CL A CL A 100,000 $985.0k0.42% 0.42% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
74 OPY ACQUISITION CORP I COM CL A COM CL A 100,000 $984.0k0.42% 0.42% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 100.0k, Q2 2022 100.0k
75 ARYA SCIENCES ACQU CORP IV CL A CL A 100,000 $981.0k0.41% 0.41% UnchangedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
76 FAT BRANDS INC *W EXP 07/16/202 FATBW FATBW 227,000 $965.0k0.41% 0.41% UnchangedShares held: Q3 2021 227.0k, Q4 2021 227.0k, Q1 2022 227.0k, Q2 2022 227.0k
77 HOLLEY INC COM HLLY HLLY 80,000 $840.0k0.36% 0.36% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 80.0k
78 COLISEUM ACQUISITION CORP CLASS A ORD SHS CLASS A ORD SHS 85,000 $827.0k0.35% 0.35% UnchangedShares held: Q3 2021 85.0k, Q4 2021 85.0k, Q1 2022 85.0k, Q2 2022 85.0k
79 PEPGEN INC COM PEPG PEPG 80,000 $794.0k0.34% 0.34% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 80.0k
80 RENOVACOR INC COM COM 388,845 $788.0k0.33% 0.33% UnchangedShares held: Q3 2021 388.8k, Q4 2021 388.8k, Q1 2022 388.8k, Q2 2022 388.8k
81 ANGIODYNAMICS INC COM ANGO ANGO 39,640 $767.0k0.32% 0.32% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 39.6k
82 MUSCLE MAKER INC COM COM 1,796,961 $692.0k0.29% 0.29% UnchangedShares held: Q3 2021 0, Q4 2021 2.0m, Q1 2022 1.8m, Q2 2022 1.8m
83 LIANBIO SPONSORED ADS LIANY LIANY 315,191 $681.0k0.29% 0.29% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 315.2k
84 STOKE THERAPEUTICS INC COM STOK STOK 48,000 $634.0k0.27% 0.27% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 48.0k
85 DOUBLEDOWN INTERACTIVE CO LT ADS DDI DDI 60,876 $588.0k0.25% 0.25% UnchangedShares held: Q3 2021 160.0k, Q4 2021 60.9k, Q1 2022 60.9k, Q2 2022 60.9k
86 GERON CORP COM GERN GERN 371,367 $576.0k0.24% 0.24% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 371.4k
87 ALKERMES PLC SHS ALKS ALKS 18,000 $536.0k0.23% 0.23% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 18.0k
88 RELMADA THERAPEUTICS INC COM RLMD RLMD 28,000 $532.0k0.22% 0.22% ReducedShares held: Q3 2021 0, Q4 2021 206.0k, Q1 2022 206.0k, Q2 2022 28.0k -178.0k -178,000 -86.4%
89 GSR II METEORA ACQUISITN COR UNIT 02/24/2027 UNIT 02/24/2027 50,000 $499.0k0.21% 0.21% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 50.0k
90 COLOMBIER ACQUISITION CORP CL A CL A 50,000 $488.0k0.21% 0.21% UnchangedShares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
91 SAGE THERAPEUTICS INC COM SAGE SAGE 15,000 $485.0k0.21% 0.21% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 15.0k
92 SURGEPAYS INC *W EXP 10/22/202 *W EXP 10/22/202 250,000 $300.0k0.13% 0.13% UnchangedShares held: Q3 2021 0, Q4 2021 250.0k, Q1 2022 250.0k, Q2 2022 250.0k
93 LIGHTNING EMOTORS INC *W EXP 05/18/202 *W EXP 05/18/202 652,173 $255.0k0.11% 0.11% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 652.2k, Q2 2022 652.2k
94 HARBOR CUSTOM DEVELOPMENT IN *W EXP 10/04/202 *W EXP 10/04/202 650,000 $244.0k0.10% 0.10% UnchangedShares held: Q3 2021 0, Q4 2021 650.0k, Q1 2022 650.0k, Q2 2022 650.0k
95 TC BIOPHARM HOLDINGS PLC *W EXP 02/10/202 TCBWF TCBWF 941,176 $223.0k0.09% 0.09% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 941.2k, Q2 2022 941.2k
96 IMMATICS N.V *W EXP 07/01/202 IMTXW IMTXW 97,467 $199.0k0.08% 0.08% UnchangedShares held: Q3 2021 97.5k, Q4 2021 97.5k, Q1 2022 97.5k, Q2 2022 97.5k
97 DIGITAL BRANDS GROUP INC COM COM 1,000,000 $195.0k0.08% 0.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
98 HARBOR CUSTOM DEVELOPMENT IN *W EXP 05/09/202 *W EXP 05/09/202 600,000 $116.0k0.05% 0.05% UnchangedShares held: Q3 2021 600.0k, Q4 2021 600.0k, Q1 2022 600.0k, Q2 2022 600.0k
99 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 10,000 $100.0k0.04% 0.04% UnchangedShares held: Q3 2021 10.0k, Q4 2021 10.0k, Q1 2022 10.0k, Q2 2022 10.0k
100 CINGULATE INC *W EXP 12/10/202 CINGW CINGW 270,000 $85.0k0.04% 0.04% UnchangedShares held: Q3 2021 0, Q4 2021 270.0k, Q1 2022 270.0k, Q2 2022 270.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
PROTAGONIST THERAPEUTICS INC PTGX PTGX 386,000 $9.1m386.0k shares
PEPPERLIME HEALTH ACQUSTN CO 735,000 $7.2m735.0k shares
QUIDEL CORP QDEL QDEL 56,000 $6.3m56.0k shares
GLOBUS MED INC GMED GMED 79,000 $5.8m79.0k shares
TANDEM DIABETES CARE INC TNDM TNDM 50,000 $5.8m50.0k shares
BICYCLE THERAPEUTICS PLC BCYC BCYC 120,000 $5.3m120.0k shares
ENVISTA HOLDINGS CORPORATION NVST NVST 105,000 $5.1m105.0k shares
QIAGEN NV 93,000 $4.6m93.0k shares
CRINETICS PHARMACEUTICALS IN CRNX CRNX 204,000 $4.5m204.0k shares
IMMUNIC INC 300,000 $3.4m300.0k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 66,000 $2.2m66.0k shares
SILENCE THERAPEUTICS PLC SLN SLN 109,000 $2.1m109.0k shares
PARDES BIOSCIENCES INC 253,000 $1.8m253.0k shares
CYTOMX THERAPEUTICS INC CTMX CTMX 663,800 $1.8m663.8k shares
SOMALOGIC INC SLGC SLGC 180,000 $1.4m180.0k shares
CTI BIOPHARMA CORP 299,800 $1.4m299.8k shares
CURIS INC 540,800 $1.3m540.8k shares
PROFOUND MED CORP PROF PROF 124,945 $1.1m124.9k shares
CUTERA INC CUTR CUTR 15,000 $1.0m15.0k shares
ACHIEVE LIFE SCIENCES INC ACHV ACHV 122,000 $924.0k122.0k shares
VIQ SOLUTIONS INC VQSSF VQSSF 489,417 $798.0k489.4k shares
VERRICA PHARMACEUTICALS INC 97,887 $794.0k97.9k shares
CALITHERA BIOSCIENCES INC CALA CALA 202,276 $82.0k202.3k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
GUARDANT HEALTH INC GH · Call GHCall 100,000 $4.0m100.0k shares New
AMYLYX PHARMACEUTICALS INC AMLX · Put AMLXPut 200,000 $3.9m200.0k shares New
PROTAGONIST THERAPEUTICS INC PTGX · Call PTGXCall 365,100 $2.9m365.1k shares Added
AXSOME THERAPEUTICS INC AXSM · Put AXSMPut 50,000 $1.9m50.0k shares New
ATHIRA PHARMA INC Call Call 200,100 $610.0k200.1k shares New
BRIDGEBIO PHARMA INC BBIO · Call BBIOCall 17,400 $158.0k17.4k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GREENLANE HLDGS INC 13G · filed 2025-02-28 10.0% new 13G 2025-02-28
SHARPS TECHNOLOGY INC 13G · filed 2025-02-05 10.0% new 13G 2025-02-05
FEMTO TECHNOLOGIES INC 13G · filed 2025-03-06 9.6% new 13G 2025-03-06